156 related articles for article (PubMed ID: 10845229)
41. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
[TBL] [Abstract][Full Text] [Related]
42. Successful unmanipulated peripheral blood progenitor cell transplantation from an HLA haploidentical 2-locus-mismatched mother in a thalassemic patient with primary graft failure after transplantation of bone marrow and cord blood from unrelated donors.
Jaing TH; Sun CF; Lee WI; Wen YC; Yang CP; Hung IJ
Pediatr Transplant; 2008 Mar; 12(2):232-4. PubMed ID: 18307674
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
[TBL] [Abstract][Full Text] [Related]
44. Sustained and full fetal hemoglobin production after failure of bone marrow transplant in a patient homozygous for beta 0-thalassemia: a clinical remission despite genetic disease and transplant rejection.
Paciaroni K; Gallucci C; De Angelis G; Alfieri C; Roveda A; Lucarelli G
Am J Hematol; 2009 Jun; 84(6):372-3. PubMed ID: 19373892
[TBL] [Abstract][Full Text] [Related]
45. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
46. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
[TBL] [Abstract][Full Text] [Related]
47. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
[TBL] [Abstract][Full Text] [Related]
48. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
49. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
51. Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO).
La Nasa G; Giardini C; Locatelli F; Argiolu F; Vassallo E; Prete A; Caocci G; Floris R; Garau P; Littera R; Mantovani D; Oppi S; Piras E; De Stefano P; Sanna MA; Mulargia M; Carcassi C; Contu L;
Haematologica; 2002 Aug; 87(8 Suppl):58-61. PubMed ID: 12412392
[TBL] [Abstract][Full Text] [Related]
52. Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency.
Bonduel M; Pozo A; Zelazko M; Raslawski E; Delfino S; Rossi J; Figueroa C; Sackmann Muriel F
Bone Marrow Transplant; 1999 Aug; 24(4):437-40. PubMed ID: 10467337
[TBL] [Abstract][Full Text] [Related]
53. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
[TBL] [Abstract][Full Text] [Related]
54. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
[TBL] [Abstract][Full Text] [Related]
55. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
[TBL] [Abstract][Full Text] [Related]
56. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
[TBL] [Abstract][Full Text] [Related]
57. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration.
Eichler H; Kern S; Beck C; Zieger W; Klüter H
Stem Cells; 2003; 21(2):208-16. PubMed ID: 12634417
[TBL] [Abstract][Full Text] [Related]
58. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia.
Jaing TH; Hung IJ; Yang CP; Tsai MH; Lee WI; Sun CF
Pediatr Transplant; 2009 Sep; 13(6):766-8. PubMed ID: 19067930
[TBL] [Abstract][Full Text] [Related]
59. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group.
Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA
Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic peripheral blood stem cell transplantation in beta-thalassemia.
Fang J; Huang S; Chen C; Zhou D; Wu Y; Bao R
Pediatr Hematol Oncol; 2002; 19(7):453-8. PubMed ID: 12217190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
